Clinical Conversations

NEJM Group
  • ٤٫٥ (٥٥)
  • طب
Clinical Conversations

From NEJM Journal Watch, this podcast features lively interviews, concise summaries, and expert commentary that busy clinicians need to stay current and improve patient care.

  1. ٠٦‏/٠٢‏/١٤٤٤ هـ

    Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2

    A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE AT THIS LINK. In treating most exacerbations of chronic obstructive pulmonary disease (COPD) the usual regimen consists of prednisone plus 5- to 7-days of antibiotics. But what if a shorter course of antibiotic therapy would do? That would be both convenient for patients and less likely to promote […]

    ١٤ من الدقائق

  2. ٢١‏/٠١‏/١٤٤٤ هـ

    Podcast 301: Monkeypox — what to look for, how to treat

    A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. This time, we look to New York for guidance on recognizing and treating monkeypox. Dr. Eric Meyerowitz of Montefiore and Dr. Stephen Baum of Einstein will lead you through the monkeypox thicket in a 17-minute chat. Included below is information for patients as well as links to some key […]

    ١٧ من الدقائق

  3. ١٣‏/٠١‏/١٤٤٤ هـ

    Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer

    A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. We’re back with another interview from this year’s IASLC conference. This time, Christine Sadlowski and Dr. Julia Rotow interview Dr. Mariano Provencio about the survival outcomes from the NADIM II trial. In that trial, patients with resectable stage III AB non-small cell lung cancer received nivolumab plus chemotherapy […]

    ١٠ من الدقائق

  4. ١١‏/٠١‏/١٤٤٤ هـ

    Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial

    A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. Interim results on overall survival in phase 3 of the IMpower010 trial were presented at this year’s meeting of the International Assosciation for the Study of Lung Cancer (IASLC). As part of the NEJM Group’s coverage of the conference, Christine Sadlowski interviewed the presenter, Dr. Enriqueta Felip. […]

    ١٥ من الدقائق

  5. ٢٩‏/١٢‏/١٤٤٣ هـ

    Podcast 297: Forget about all that vitamin D testing!!

    A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. THE USUAL AUDIO FILE IS AVAILABLE BELOW Steven Cummings has co-written a take-no-prisoners editorial in the New England Journal of Medicine. The topic? Vitamin D supplements. The conclusion? “…providers should stop screening for 25-hydroxyvitamin D levels or recommending vitamin D supplements, and people should stop taking vitamin D […]

    ١٣ من الدقائق

  6. ٢١‏/١٢‏/١٤٤٣ هـ

    Podcast 296: A roundtable on the question, Why are young internists flocking to the hospitalist practice style?

    A VIDEO RECORDING OF THIS ROUNDTABLE IS AVAILABLE CLICK HERE. THE USUAL AUDIO FILE IS AVAILABLE BELOW Your host is old enough to remember when hospital corridors featured physicians with little black bags, scurrying around to see their patients. That’s no longer true, of course. Most of the physicians seen in those corridors these days are white-coated employees. The […]

    ٣٠ من الدقائق

  7. ٠٧‏/١٢‏/١٤٤٣ هـ

    Podcast 295: How should clinicians manage severe (but asymptomatic) carotid artery stenosis while awaiting CREST-2’s results?

    CREST-2’s results are probably more than a year away. In the meantime, what to do about diagnosed severe (but asymptomatic) carotid stenosis? Recent results suggest that medical management compares favorably with the surgical approach. In this edition, we address the question with a conversation between Dr. Allan Brett, NEJM Journal Watch‘s editor-in-chief, and Dr. Seemant Chaturvedi, […]

    ١٦ من الدقائق

  8. ٣٠‏/١١‏/١٤٤٣ هـ

    Podcast 294: PD-1 blockade in locally advanced rectal cancer

    Locally advanced rectal cancer usually receives a three-part treatment: chemotherapy followed by radiotherapy and then surgery. In a small-cohort study presented at this year’s ASCO conference researchers used a PD-1 inhibitor — dostarlimab — every three weeks for 6 months against the disease. All patients had mismatch repair deficient tumors. No other treatments were needed however, […]

    ١٣ من الدقائق
مشاهدة الكل (٥٠)

٤٫٥
من ٥
‫٥٥ من التقييمات‬

حول

From NEJM Journal Watch, this podcast features lively interviews, concise summaries, and expert commentary that busy clinicians need to stay current and improve patient care.

المعلومات

  • قناة
    NEJM Group
  • صناع العمل
    NEJM Group
  • سنوات النشاط
    ١٤٢٩ هـ - ١٤٤٤ هـ
  • الحلقات
    ٥٠
  • التقييم
    ملائم
  • حقوق النشر
    © 2008-2024 NEJM Journal Watch
  • موقع البرنامج على الويب
    Clinical Conversations

المزيد من NEJM Group

قد يعجبك أيضًا

للاستماع إلى حلقات ذات محتوى فاضح، قم بتسجيل الدخول.

اطلع على آخر مستجدات هذا البرنامج

قم بتسجيل الدخول أو التسجيل لمتابعة البرامج وحفظ الحلقات والحصول على آخر التحديثات.
تحديد بلد أو منطقة

أفريقيا والشرق الأوسط، والهند

آسيا والمحيط الهادئ

أوروبا

أمريكا اللاتينية والكاريبي

الولايات المتحدة وكندا